LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1209 | 2376 | 4093 | 0.5805 | 0.4045 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1209 | 2145 | 4093 | 0.5241 | 0.3244 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1097 | 2687 | 3769 | 0.7128 | 0.5949 |
MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1235 | 1366 | 4513 | 0.3026 | 0.0397 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 962 | 1801 | 10605 | 0.1698 | 0.0870 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1235 | 4089 | 4513 | 0.9059 | 0.8704 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 658 | 1127 | 3846 | 0.2930 | 0.1471 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 1235 | 3689 | 4513 | 0.8173 | 0.7484 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 962 | 1576 | 10605 | 0.1486 | 0.0637 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1235 | 3343 | 4513 | 0.7406 | 0.6429 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 658 | 1050 | 3846 | 0.2730 | 0.1229 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1209 | 2044 | 4093 | 0.4994 | 0.2894 |
MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1209 | 3667 | 4093 | 0.8959 | 0.8523 |
MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 1209 | 3276 | 4093 | 0.8004 | 0.7167 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1097 | 3198 | 3769 | 0.8484 | 0.7861 |
MCF7 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1209 | 3379 | 4093 | 0.8256 | 0.7524 |
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1401 | 3297 | 4223 | 0.7807 | 0.6718 |
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 2 | P24 | 72 | hr | 1401 | 3062 | 4223 | 0.7251 | 0.5885 |
BT-20 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1097 | 3250 | 3769 | 0.8622 | 0.8056 |
SK-BR-3 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1401 | 3393 | 4223 | 0.8034 | 0.7058 |